Caxton Associates LP Avanos Medical, Inc. Transaction History
Caxton Associates LP
- $2.65 Billion
- Q3 2024
A detailed history of Caxton Associates LP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 8,612 shares of AVNS stock, worth $138,050. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,612
Previous 17,035
49.45%
Holding current value
$138,050
Previous $339,000
39.23%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding AVNS
# of Institutions
274Shares Held
42.2MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$85.3 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$50.8 Million3.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$41.5 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.37MShares$37.9 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $745M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...